Physician profile
Gillian Adams
NPI 1912086794
$1,003.18
in general payments reported to CMS, 2019-2025
14 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.82 · 2023: $255 · 2024: $236 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.11 | 2023-2025 | Vraylar |
| Novo Nordisk INC | $139.37 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Idorsia Pharmaceuticals US INC | $123.17 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $114.86 | 2023 | Rexulti |
| Merck Sharp & Dohme LLC | $46.10 | 2025 | Gardasil 9, Capvaxive |
| Lilly USA, LLC | $41.93 | 2025 | Zepbound, Mounjaro |
| Inspire Medical Systems, INC. | $36.70 | 2025 | Inspire |
| Allergan, INC. | $31.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.59 | 2025 | Jardiance |
| Pfizer INC. | $24.27 | 2024 | |
| Sanofi-Aventis U.S. LLC | $23.32 | 2025 | |
| Chiesi USA, INC. | $16.34 | 2024 | Kengreal |
| Gilead Sciences, INC. | $16.32 | 2019 | |
| Exact Sciences Corporation | $14.60 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gillian Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.